We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Delivery System Facilitates Prosthetic Valve Placement

By HospiMedica International staff writers
Posted on 13 Apr 2014
Innovative heart valve technology features a rapid deployment system that facilitates aortic valve replacement (AVR) procedures.

The Edwards Intuity Elite Valve System is a bovine pericardial heart valve based on the Carpentier-Edwards Perimount heart valve design, and features an innovative balloon-expandable frame designed to facilitate rapid annular placement and reduce overall AVR procedural time. More...
The rapid deployment delivery system is based on a flexible, low profile base that is designed to assist access and visibility through smaller incisions, thus improving safety and outcomes and leading to shorter recovery times.

The Carpentier-Edwards Perimount heart valve is designed with an incomplete supra-annular configuration with an intra-annular component. It is constructed of an Elgiloy stent at the orifice and commissures for flexibility. The leaflets are produced by computer-aided design for optimal leaflet-to-stent matching, using tissue deflection testing that enables the leaflets to be matched accurately. The pericardium is fixed by a stress-free process using glutaraldehyde. The Edwards Intuity Elite Valve System is a product of Edwards Lifesciences (Irvine, CA, USA), and has received the European Community CE marking of approval.

“We're encouraged by the introduction of heart valve technologies that are developed to facilitate a minimally invasive approach for the improved treatment of patients with aortic valve disease,” said Prof. Michael Borger, MD, PhD, of the Leipzig Heart Center (Germany). “Our experience with the Edwards Intuity platform has shown the ability to implant the valve through smaller incisions, with significantly reduced cross-clamp time and improved hemodynamics. This less-invasive, more efficient surgical approach should benefit patients during and after their procedure.”

“We've enhanced the Edwards Intuity design to further meet the needs of patients, physicians and hospitals with a valve and procedure that can be readily incorporated into the surgeon's treatment offerings,” said Donald E. Bobo, Jr., vice president of heart valve therapy at Edwards Lifesciences. “We believe the Edwards Intuity platform can greatly expand the population of patients who receive the less-invasive approach with important clinical and cost benefits.”

Related Links:

Edwards Lifesciences



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.